en | fr | EVENTSBrussels 27.01.2010
Managing risks: A closer look at the legislative proposals on pharmacovigilance
Expert meeting
European Parliament - Brussels
Wednesday 27 January 2010 12:30–15:00
European Parliament - József Antall building , Room 6Q1
60, rue Wiertz -1047 Brussels
A public meeting hosted and chaired by MEP Rapporteurs Linda Mc Avan (S&D) and Michèle Rivasi (Greens/EFA) and co-hosted by MEPs Philippe Juvin (PPE) and Antonyia Parvanova (ALDE)
PROGRAMME
| |
Wednesday 27 January 2010 12:30-15:00
|
| 12:00–12:30 |
Registration
|
|
13:00–13:10
|
Introduction
by the Chairs, MEP Linda Mc Avan and MEP Michèle Rivasi
|
|
13:10–13:20
|
Medicines' Adverse Reactions are a public health issue: a proactive approach is needed
Prof. Joan-Ramon Laporte, Catalan Institute of Pharmacology (ICF), Spain
|
|
13:20 –13:30
|
How to deal with adverse drug reactions reports? The role of National and regional pharmacovigilance centres
Dr. Thomas Stammschulte, German Medical Association (Arzneimittelkommission der deutschen Ärzteschaft, akdä), Germany
|
| 13:30-13:45 |
The European Commission's Pharmacovigilance proposals: more than a technical issue
Florence Vandevelde, Medicines in Europe Forum
|
| 13:45-13:55 |
Direct patient reporting: what works and why it matters. Findings of an international survey
Prof. Andrew Herxheimer, UK Cochrane Collaboration, United-Kingdom
|
| 13:55-14:05 |
Access to pharmacovigilance information – Patients and consumers' demands
Interventions from:
Martine Van Hecke, Belgian Consumers' Organisation Test-Achats
Ilaria Passarani, European Consumers' Organisation BEUC
|
| 14:05-14:15 |
Comments by the co-chairs, MEP Philippe Juvin and MEP Antonyia Parvanova |
| 14:15-14:45 |
Open discussion moderated by MEP Michèle Rivasi |
| 14:45-15:00 |
Conclusion by the MEPs |
Simultaneous translation will be available in English and French
Light lunch and refreshments will be available before the start of the meeting at 12:30h
An overflow room will be available with live broadcast of the meeting
This event is facilitated by:
The Greens/EFA in the European Parliament,Association Internationale de la Mutualité (AIM), European Consumers' Organisation (BEUC), Health Action International (HAI) Europe, the International Society of Drug Bulletins (ISDB) and Medicines in Europe Forum (MiEF).
